Literature DB >> 8705673

Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation.

P E Simms1, T M Ellis.   

Abstract

CD69 is a lymphoid activation antigen whose rapid expression (< or = 2 h postactivation) makes it amenable for the early detection of T-cell activation and for subset activation analyses. In the present study we evaluated the utility of flow cytometric detection of CD69 expression by T cells activated with polyclonal stimuli (anti-CD3 and staphylococcal enterotoxin B [SEB]) and oligoclonal stimuli (tetanus toxoid and allogeneic cells) using flow cytometry. Following activation of T cells with anti-CD3 or SEB, CD69 is detectable at < or = 4 h following activation, with anti-CD3 peaks at 18 to 48 h. Dose titration experiments indicated that CD69 expression largely paralleled that in [3H]thymidine incorporation assays, although the former offered a more sensitive measure of T-cell activation at limiting doses of activator than [3H]thymidine incorporation when cells were activated with either anti-CD3 or SEB. However, activation of T cells with either tetanus toxoid or allogeneic stimulator cells failed to induce detectable CD69 expression at up to 7 days of culture. Subset analyses of anti-CD3- and SEB-activated T cells indicated that populations other than T cells can express CD69 following stimulation with T-cell-specific stimuli, indicating that CD69 can be induced indirectly in non-T cells present in the population. These findings indicate that CD69 is a useful marker for quantifying T-cell and T-cell subset activation in mixed populations but that its utility might be restricted to potent stimuli that are characterized by their ability to activate large numbers of cells with rapid kinetics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705673      PMCID: PMC170336          DOI: 10.1128/cdli.3.3.301-304.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

Review 1.  T-cell responses to Mls and to bacterial proteins that mimic its behavior.

Authors:  C A Janeway; J Yagi; P J Conrad; M E Katz; B Jones; S Vroegop; S Buxser
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

2.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C.

Authors:  R Testi; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

Review 3.  Immunological memory.

Authors:  C R Mackay
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

Review 4.  The activation antigen CD69.

Authors:  S F Ziegler; F Ramsdell; M R Alderson
Journal:  Stem Cells       Date:  1994-09       Impact factor: 6.277

5.  Rapid flow cytometric method for measuring lymphocyte subset activation.

Authors:  V C Maino; M A Suni; J J Ruitenberg
Journal:  Cytometry       Date:  1995-06-01

6.  Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.

Authors:  F Gerosa; M Tommasi; C Benati; G Gandini; M Libonati; G Tridente; G Carra; G Trinchieri
Journal:  Cell Immunol       Date:  1993-09       Impact factor: 4.868

7.  In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

Authors:  J D McMannis; R I Fisher; S P Creekmore; D P Braun; J E Harris; T M Ellis
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

8.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.

Authors:  L L Lanier; D W Buck; L Rhodes; A Ding; E Evans; C Barney; J H Phillips
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

Authors:  T Hara; L K Jung; J M Bjorndahl; S M Fu
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.

Authors:  R De Maria; M G Cifone; R Trotta; M R Rippo; C Festuccia; A Santoni; R Testi
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  69 in total

1.  IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

Authors:  Gordana Konjević; Viktor Jović; Vladimir Jurisić; Sinisa Radulović; Svetislav Jelić; Ivan Spuzić
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

2.  Trogocytosis-Mediated Intracellular Signaling in CD4+ T Cells Drives TH2-Associated Effector Cytokine Production and Differentiation.

Authors:  Jim Reed; Scott A Wetzel
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

3.  NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.

Authors:  Crescent L Combe; Tyler J Curiel; Magali M Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Binase does not induce polyclonal T-cell response.

Authors:  P V Zelenikhin; G V Cherepnev; F Kern; O N Ilinskaia
Journal:  Dokl Biol Sci       Date:  2006 Mar-Apr

5.  Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.

Authors:  M Paz Morante; J Briones; E Canto; H Sabzevari; R Martino; J Sierra; J L Rodriguez-Sanchez; S Vidal
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

6.  CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

Authors:  Rajendra N Damle; Sonal Temburni; Carlo Calissano; Sophia Yancopoulos; Taraneh Banapour; Cristina Sison; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2007-08-07       Impact factor: 22.113

Review 7.  Flow cytometry applications in pharmacodynamics and drug delivery.

Authors:  M Ramanathan
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 8.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Production of genetically engineered biotinylated interleukin-2 and its application in a rapid nonradioactive assay for T-cell activation.

Authors:  Robert A Jordan; Mark T Preissler; Jeffrey A Banas; Edmund J Gosselin
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.

Authors:  Neil M Ampel; Larissa A Kramer; Lijin Li; Deborah S Carroll; Kathleen M Kerekes; Suzanne M Johnson; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.